[Treating chronic occlusive arterial disease].

MMW Fortschr Med

Medizinische Klinik Nord-Angiologie/Diabetologie, Klinikum Dortmund gGmbH.

Published: May 2005

The basis for the treatment of chronic occlusive arterial disease, in whatever stage, is the management of the cardiovascular risk factors as a secondary preventive measure. In the absence of contraindications, every symptomatic POAD patient should be given an antiplatelet agent. In stage I disease, prevention of progression is the overriding aim. In stage II, risk factor management and an antiplatelet agent are indicated. In addition to a walking exercise program, the reconstruction of occluded vessels may be indicated. The decision to apply interventional treatment or vascular surgery in stage II and IV disease; must be based on the morphology of the vascular lesion and concomitant diseases. If revascularization is not possible, treatment with PGE1 is recommended. As a life-saving measure when all else has failed, an amputation must be done.

Download full-text PDF

Source

Publication Analysis

Top Keywords

chronic occlusive
8
occlusive arterial
8
antiplatelet agent
8
stage disease
8
[treating chronic
4
arterial disease]
4
disease] basis
4
basis treatment
4
treatment chronic
4
arterial disease
4

Similar Publications

Background: This video article describes the use of bone-anchored prostheses for patients with transtibial amputations, most often resulting from trauma, infection, or dysvascular disease. Large studies have shown that about half of all patients with a socket-suspended artificial limb experience limited mobility and limited prosthesis use because of socket-related problems. These problems occur at the socket-residual limb interface as a result of a painful and unstable connection, leading to an asymmetrical gait and subsequent pelvic and back pain.

View Article and Find Full Text PDF

Percutaneous coronary intervention (PCI) in pediatric patients is rare, especially in cases of chronic total occlusion (CTO) of the left main coronary artery (LMCA), with scarce evidence. These are associated with poorer prognostic outcomes, highlighting the need for timely intervention. In addition, its unique and entirely different pathophysiology compared to that well-studied in adults makes it a clinically challenging scenario for diagnosis, treatment, and follow-up.

View Article and Find Full Text PDF

Unmasking Culprit Complex Infero-Posterior STEMI: Navigating Ad Hoc RCA CTO PCI.

JACC Case Rep

January 2025

Section of Cardiovascular Diseases, White River Health, Batesville, Arkansas, USA.

Patients presenting with acute coronary syndrome with ST-segment elevation myocardial infarction require rapid and decisive interventions to restore blood flow to the affected myocardium, minimizing ischemic damage. This case report is particularly unique because it involves a patient presenting with ST-segment elevation myocardial infarction, where the culprit lesion was an occluded coronary artery graft with an extensive thrombus burden. The complexity of this case necessitated a strategic shift to revascularize the chronically occluded native vessel instead of the graft.

View Article and Find Full Text PDF

A blunt needle endoluminal cracking over the strained through-and-through wire for balloon crossing the heavy calcification and chronic total occlusion in critical limb ischemia.

J Vasc Surg Cases Innov Tech

April 2025

Division of Vascular and Transplant Surgery, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

The Achilles heel of revascularization in chronic limb-threatening ischemia is that a balloon is sometimes unable to cross the severely calcified below-the-knee lesion. We presented a new technique for crossing this lesion using the blunt needle endoluminal cracking over the strained through and through wire (BECOST) technique.

View Article and Find Full Text PDF

Background: Intravascular imaging (IVI) complements coronary angiography and may help prevent coronary artery perforation (CAP) during percutaneous coronary intervention (PCI).

Objectives: The authors evaluated whether IVI-guided PCI is associated with a lower risk of PCI-related CAP in a real-world cohort.

Methods: This observational study analyzed consecutive PCI procedures from January 2006 to October 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!